Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers worldwide, primarily due to its robust desmoplastic stroma and immunosuppressive tumor microenvironment (TME), which facilitate tumor progression and metastasis. In addition, fibrous tissue leads to sparse vasculature, high inter...
Main Authors: | Maria Urbanova, Marina Cihova, Verona Buocikova, Jan Slopovsky, Peter Dubovan, Daniel Pindak, Miroslav Tomas, Laura García-Bermejo, Mercedes Rodríguez-Garrote, Julie Earl, Yvonne Kohl, Agapi Kataki, Maria Dusinska, Bruno Sainz, Jr., Bozena Smolkova, Alena Gabelova |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223009708 |
Similar Items
-
The Metastatic Process through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy
by: Bozena Smolkova, et al.
Published: (2022-12-01) -
Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?
by: Julie Earl, et al.
Published: (2023-05-01) -
Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
by: Verona Buocikova, et al.
Published: (2020-12-01) -
Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
by: Sona Ciernikova, et al.
Published: (2020-06-01) -
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
by: Lenka Trnkova, et al.
Published: (2024-05-01)